These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 34769517)

  • 1. Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease.
    Martínez-Menárguez JÁ; Martínez-Alonso E; Cara-Esteban M; Tomás M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragmentation of the Golgi complex of dopaminergic neurons in human substantia nigra: New cytopathological findings in Parkinson's disease.
    Tomás M; Martínez-Alonso E; Martínez-Martínez N; Cara-Esteban M; Martínez-Menárguez JA
    Histol Histopathol; 2021 Jan; 36(1):47-60. PubMed ID: 33078843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
    Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
    Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein impairs macroautophagy: implications for Parkinson's disease.
    Winslow AR; Chen CW; Corrochano S; Acevedo-Arozena A; Gordon DE; Peden AA; Lichtenberg M; Menzies FM; Ravikumar B; Imarisio S; Brown S; O'Kane CJ; Rubinsztein DC
    J Cell Biol; 2010 Sep; 190(6):1023-37. PubMed ID: 20855506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity.
    Kim H; Calatayud C; Guha S; Fernández-Carasa I; Berkowitz L; Carballo-Carbajal I; Ezquerra M; Fernández-Santiago R; Kapahi P; Raya Á; Miranda-Vizuete A; Lizcano JM; Vila M; Caldwell KA; Caldwell GA; Consiglio A; Dalfo E
    Mol Neurobiol; 2018 Sep; 55(9):7533-7552. PubMed ID: 29429047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review.
    Chen ML; Wu RM
    J Biomed Sci; 2018 Jun; 25(1):52. PubMed ID: 29903014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
    Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
    Singh PK; Muqit MMK
    Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
    Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
    Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; Labaer J; Rochet JC; Bonini NM; Lindquist S
    Science; 2006 Jul; 313(5785):324-8. PubMed ID: 16794039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-synuclein and Parkinson's disease: the first roadblock.
    Chua CE; Tang BL
    J Cell Mol Med; 2006; 10(4):837-46. PubMed ID: 17125588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein impairs ferritinophagy in the retinal pigment epithelium: Implications for retinal iron dyshomeostasis in Parkinson's disease.
    Baksi S; Singh N
    Sci Rep; 2017 Oct; 7(1):12843. PubMed ID: 28993630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Parkinson disease protein α-synuclein inhibits autophagy.
    Winslow AR; Rubinsztein DC
    Autophagy; 2011 Apr; 7(4):429-31. PubMed ID: 21157184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Sheehan P; Yue Z
    Neurosci Lett; 2019 Apr; 697():59-65. PubMed ID: 29627340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
    Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
    Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.